Clinical trialPhase 3
REGEND001 in emphysematous COPD
NCT07828353
Planned 102 участника, multicenter randomized blinded placebo-controlled; из собственных airway basal stem cells пациента.
No news refers to this card yet.
Scales
Identifiers
- NCT
- NCT07828353
Original sources
Details
- Phase
- Phase 3
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.